Filter
563
Text search:
laboratory
biosafety
Featured
Recommendations
92
New Publications
138
Language
Document type
No document type
289
Guidelines
128
Studies & Reports
55
Manuals
46
Strategic & Response Plan
24
Training Material
8
Situation Updates
5
Fact sheets
5
Resource Platforms
2
Brochures
1
Countries / Regions
India
33
Sierra Leone
21
Africa
18
Nigeria
17
Western and Central Europe
17
Latin America and the Carribbean
16
Ghana
12
Kenya
12
Rwanda
12
Liberia
11
Eastern Europe
11
Uganda
10
Brazil
10
Global
10
Ethiopia
8
West and Central Africa
8
Zambia
7
Mozambique
7
Ukraine
7
East and Southern Africa
7
Congo, Democratic Republic of
6
Philippines
6
Tanzania
6
Bangladesh
6
Angola
6
Middle East and North Africa
6
Nepal
5
South–East Asia Region
5
Russia
5
Guinea
4
Syria
4
Eastern Europe and Central Asia
4
Spain
4
Guinea-Bissau
3
Pakistan
3
South Africa
3
Malawi
3
Namibia
3
Western Pacific Region
3
Tajikistan
3
Burkina Faso
2
Cameroon
2
Germany
2
Myanmar / Burma
2
Senegal
1
USA
1
Saudi Arabia
1
Zimbabwe
1
South Sudan
1
Afghanistan
1
Lebanon
1
Chad
1
China
1
Mauritania
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Burundi
1
Colombia
1
Yemen
1
Asia
1
Poland
1
Italy
1
Laos
1
Bulgaria
1
Romania
1
Moldova
1
Slovakia
1
Georgia
1
Vietnam
1
North America
1
Gabon
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
202
Pharmacy & Technologies
52
Clinical Guidelines
46
Key Resources
22
Public Health
21
Women & Child Health
5
Capacity Building
1
Toolboxes
COVID-19
123
TB
102
Rapid Response
78
Ebola
60
AMR
37
HIV
14
Zika
11
NTDs
11
Conflict
9
Polio
8
Pharmacy
7
Caregiver
6
Planetary Health
6
Specific Hazards
4
Cholera
3
Natural Hazards
3
Health Financing Toolbox
2
Mental Health
1
Global Health Education
1
27 May 2021
All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public health scenarios, recognizing that there is no one-size-fits-all approach to managing cases and o
...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a
...
The animal health subsector within the agriculture sector is the gatekeeper of antimicrobial resistance (AMR) in livestock, aquaculture, animal products, and the immediate animal environment. In support of member countries taking responsibility for and moving forward with putting AMR monitoring and
...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Procedura per l’esecuzione di riscontri diagnostici in pazienti deceduti con infezione da SARS-CoV-2
Rapporto ISS COVID-19, n. 6/2020
Gruppo di Lavoro ISS Cause di morte COVID-19
Versione del 27 marzo 2020
This document is a guide for national authorities who are responsible for managing public health responses to COVID-19
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i
...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may
...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o
...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti
...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardinal as an effective package of services
that diminis
...
